Matthew Sparks, MD
@nephro_sparks
PD @DukeKidney & @VADurham|@RenalFellowNtwk|@ASNKidney Comm Dir|@NephJC|#NephMadness creator|#NSMC APD|@kidneynews|@Neph_SIM Ad Board|🏳️🌈ally
ID: 24415922
https://medicine.duke.edu/faculty/matthew-sparks-md 14-03-2009 19:26:46
48,48K Tweet
21,21K Followers
7,7K Following
The FLOW trial and secondary analysis of the SELECT trial have demonstrated important kidney benefits of semaglutide, ushering in another medication option to treat diabetic kidney disease. bit.ly/KN160832 Benjamin Catanese Matthew Sparks, MD
Applications for the 2025 National Kidney Foundation #NephSIM Nephrons Program for medical students & residents interested in learning more about #nephrology careers will open in... ...2⃣ weeks! nephsim.com/nephsim-nephro… NKF Nephrology Professionals #FOAMed #MedEd Check out the 2024 Program 👇
Applications are now open for the 2025 #NephSIM Nephrons National Kidney Foundation Program! 🫘 For 🇺🇸🇵🇷 medical students & residents (who have not yet applied to fellowship) who are interested in learning more about #nephrology/careers Apply here by 11/1: nephsim.com/nephsim-nephro… #FOAMed #MedEd
As the kidneys enlarge and renal function decreases, quality of life declines.. and you’ll see an increase in pain, anxiety and depression … #PKDAwarenessDay Access our paper on PKD and mental health here👇LLUHphysicians lnkd.in/g35dnKYq